114.42k followers • 23 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Curated by Yahoo Finance
Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.How do we pick these stocks?
This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.How are these weighted?
The stocks on this watchlist are weighted equally at the time they were added.
To learn what every company on this list is doing that involves cannabis, read this story.
|Watchlist||Change today||1-month return||1-year return||Total return|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|ABBV||AbbVie Inc.||90.11||+0.48||+0.54%||4:03 pm GMT-4||10.00M||7.06M||159.03B|
|BUD||Anheuser-Busch InBev SA/NV||57.56||-0.44||-0.76%||4:00 pm GMT-4||1.45M||1.79M||113.16B|
|MO||Altria Group, Inc.||39.84||-1.02||-2.50%||4:03 pm GMT-4||22.67M||7.70M||74.04B|
|SMG||The Scotts Miracle-Gro Company||149.13||-5.61||-3.63%||4:00 pm GMT-4||753.21k||381.00k||8.32B|
|WEED.TO||Canopy Growth Corporation||21.57||-0.01||-0.05%||4:00 pm GMT-4||1.72M||1.37M||8.01B|
|TAP||Molson Coors Beverage Company||34.31||-0.75||-2.14%||4:04 pm GMT-4||4.95M||2.10M||7.48B|
|CGC||Canopy Growth Corporation||16.36||-0.04||-0.24%||4:00 pm GMT-4||2.10M||3.86M||6.06B|
|GWPH||GW Pharmaceuticals plc||100.18||-1.83||-1.79%||4:00 pm GMT-4||654.44k||387.65k||3.12B|
|CRON||Cronos Group Inc.||5.29||+0.05||+0.95%||4:00 pm GMT-4||2.17M||3.52M||1.85B|
|ACB||Aurora Cannabis Inc.||6.53||-0.36||-5.22%||4:00 pm GMT-4||6.91M||3.51M||733.20M|
|TLRY||Tilray, Inc.||5.34||-0.09||-1.66%||4:00 pm GMT-4||5.15M||5.89M||679.13M|
|CTST||CannTrust Holdings Inc.||0.638||-||-||4:02 pm GMT-4||-||-||251.15M|
|NBEV||NewAge, Inc.||1.8||-||-||4:00 pm GMT-4||2.31M||3.00M||186.56M|
|CRBP||Corbus Pharmaceuticals Holdings, Inc.||1.9||-0.06||-3.06%||4:00 pm GMT-4||33.02M||3.65M||155.25M|
|TGOD.TO||The Green Organic Dutchman Holdings Ltd.||0.34||-0.01||-2.86%||4:00 pm GMT-4||590.91k||1.10M||130.78M|
|TRST.TO||CannTrust Holdings Inc.||0.91||-||-||4:00 pm GMT-4||321.02k||-||128.48M|
|TGODF||The Green Organic Dutchman Holdings Ltd.||0.256||-0.01||-4.30%||3:57 pm GMT-4||387.17k||632.41k||97.73M|
|CANN||General Cannabis Corp||0.3175||+0.02||+5.83%||3:58 pm GMT-4||85.42k||135.95k||18.64M|
|TRTC||Terra Tech Corp.||0.0734||+0.00||+2.16%||3:58 pm GMT-4||239.43k||523.09k||15.09M|
|MJ||ETFMG Alternative Harvest ETF||11.18||-0.11||-0.97%||4:00 pm GMT-4||670.33k||605.93k||-|
When you think about marijuana stocks, popular Canadian cannabis companies including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) likely come to mind. Illinois-based Cresco Labs (OTC: CRLBF) had an impressive start to the year with its first-quarter results, and it continued to shine with its stunning second-quarter results, reported on Aug. 20. Shares of Cresco are down 20% so far this year, while Aurora's and Canopy's shares have lost 73% and 22%, respectively.
Investors hope that the popular pot stock will recover this year. But in order for that to happen, it has to get a lot right.
Canadian cannabis sales are continuing to balloon amidst the coronavirus pandemic. The latest data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were up 8% from May's total sales. Despite their historic difficulties in generating cash, paying off debts, and avoiding massive writedowns, Aphria (NASDAQ: APHA) and Aurora Cannabis (NYSE: ACB) could be poised to claim shares of the rapidly expanding marketplace.